False Claims Act - G2 Intelligence

Weekly Enforcement Report: Medical Centers Pay Big

Recently announced enforcement actions saw three big settlements, with two of those coming from medical centers.

Though last week’s cases didn’t involve labs or lab testing, most were FCA-related issues including inflated claims.

Last week saw the usual False Claims Act and kickback-related charges, with the biggest action involving urine drug testing.

In this month’s Labs in Court roundup, a medical device company and genetic testing company each win key victories.

Start a Free Trial for immediate access to this article

Already a member? Log in here

While labs were absent from recent enforcement actions, last week saw kickback schemes involving DME companies and a medical device company.